Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes.

OBJECTIVES To evaluate demographics, magnetic resonance imaging (MRI) measures, and vascular risk among mild cognitive impairment (MCI) subtypes. DESIGN Cross-sectional study. SETTING Both clinics and the community. PARTICIPANTS A total of 153 subjects with MCI, 218 cognitively normal older individuals (controls), and 68 patients with Alzheimer disease. MAIN OUTCOME MEASURES Classification of subjects with MCI according to current subtype diagnostic convention based on neuropsychological performance, estimates of vascular risk based on medical history, research MRI unless there was a specific contraindication, and apolipoprotein E genotype. RESULTS Of the 153 subjects with MCI, 65 were diagnosed with amnestic single-domain, 46 with amnestic multiple-domain, 27 with nonamnestic single-domain, and 15 with nonamnestic multiple-domain MCI. Analyses of control, MCI, and Alzheimer disease cases revealed significant differences in brain and hippocampal volumes between each group. Post hoc analyses of MRI measures among the MCI subtypes found that patients with amnestic single-domain MCI had significantly less brain atrophy and that hippocampal volume differed significantly from controls for the 2 amnestic forms of MCI. Apolipoprotein E genotype prevalence was significantly greater in the amnestic and nonamnestic subtypes of MCI. Conversely, the nonamnestic subtypes were more likely to have increased vascular risk and to be African American. CONCLUSIONS Amnestic forms of MCI appear to have demographic, genetic, and MRI findings suggestive of Alzheimer disease pathology, whereas the nonamnestic forms of MCI have findings suggestive of vascular disease. Importantly, however, all subjects with MCI showed evidence of brain injury, and the biological differences among subtypes are relatively subtle beyond the memory vs nonmemory groupings.

[1]  C. Jack,et al.  FLAIR histogram segmentation for measurement of leukoaraiosis volume , 2001, Journal of magnetic resonance imaging : JMRI.

[2]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[3]  E. Tangalos,et al.  CME Practice parameter: , 2022 .

[4]  C. Jack,et al.  11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. , 2008, Brain : a journal of neurology.

[5]  Charles DeCarli,et al.  Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment , 2003, The Lancet Neurology.

[6]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[7]  Nick C Fox,et al.  Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease , 1999, The Lancet.

[8]  D. Bennett,et al.  Alzheimer disease in the US population: prevalence estimates using the 2000 census. , 2003, Archives of neurology.

[9]  C. Jack,et al.  Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial , 2002, Journal of Molecular Neuroscience.

[10]  J. Price,et al.  Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.

[11]  A. Heyman,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1993, Neurology.

[12]  M. Farlow,et al.  Differential qualitative responses to rivastigmine in APOE epsilon 4 carriers and noncarriers. , 2004, The pharmacogenomics journal.

[13]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[14]  J. Tuomilehto,et al.  Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.

[15]  W. Jagust,et al.  Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers , 1992, Neurology.

[16]  David A. Bennett,et al.  Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.

[17]  Paul Maruff,et al.  β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease , 2007 .

[18]  M. Viitanen,et al.  PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment , 2007, Neurology.

[19]  N. Butters,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery , 1994, Neurology.

[20]  Christine Delmaire,et al.  Prevalence of Subcortical Vascular Lesions and Association With Executive Function in Mild Cognitive Impairment Subtypes , 2007, Stroke.

[21]  Patrizia Mecocci,et al.  Mild cognitive impairment: a systematic review. , 2007, Journal of Alzheimer's disease : JAD.

[22]  J. Becker,et al.  Differential cortical atrophy in subgroups of mild cognitive impairment. , 2005, Archives of neurology.

[23]  C. Jack,et al.  Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. , 2007, Archives of neurology.

[24]  B. Miller,et al.  Subtype of Mild Cognitive Impairment and Progression to Dementia and Death , 2006, Dementia and Geriatric Cognitive Disorders.

[25]  John Breitner,et al.  Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. , 2003, Archives of neurology.

[26]  S. Riedel-Heller,et al.  Is Mortality Increased in Mildly Cognitively Impaired Individuals? , 2006, Dementia and Geriatric Cognitive Disorders.

[27]  D. Teichberg,et al.  Local histogram correction of MRI spatially dependent image pixel intensity nonuniformity , 1996, Journal of magnetic resonance imaging : JMRI.

[28]  R. Mayeux,et al.  Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. , 2005, Archives of neurology.

[29]  J. Morris,et al.  The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease Centers , 2006, Alzheimer disease and associated disorders.

[30]  D. Bennett,et al.  Mild cognitive impairment: is it Alzheimer's disease or not? , 2005, Journal of Alzheimer's disease : JAD.

[31]  D. Harvey,et al.  Measures of brain morphology and infarction in the framingham heart study: establishing what is normal , 2005, Neurobiology of Aging.

[32]  Steven Shea,et al.  Race-Ethnic Disparities in the Impact of Stroke Risk Factors: The Northern Manhattan Stroke Study , 2001, Stroke.

[33]  G. Linazasoro,et al.  IMAGING β-AMYLOID BURDEN IN AGING AND DEMENTIA , 2008, Neurology.

[34]  K. Hall,et al.  International Studies in Dementia With Particular Emphasis on Populations of African Origin , 2006, Alzheimer disease and associated disorders.

[35]  P. Wolf,et al.  The lifetime risk of stroke: estimates from the Framingham Study. , 2006, Stroke.

[36]  H. Engler,et al.  PET imaging of amyloid deposition in patients with mild cognitive impairment , 2008, Neurobiology of Aging.

[37]  R. Petersen Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[38]  C. DeCarli,et al.  Brain Behavior Relationships Among African Americans, Whites, and Hispanics , 2008, Alzheimer disease and associated disorders.

[39]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[40]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[41]  J. Kaye,et al.  Brain volume loss in MCI predicts dementia , 2006, Neurology.

[42]  C. Jack,et al.  Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia , 2002, Neurology.

[43]  Ronald C Petersen,et al.  Challenges of epidemiological studies of mild cognitive impairment. , 2004, Alzheimer disease and associated disorders.

[44]  J. Morris,et al.  Mild cognitive impairment as a clinical entity and treatment target. , 2005, Archives of neurology.

[45]  D A Bennett,et al.  State-specific projections through 2025 of Alzheimer disease prevalence , 2004, Neurology.

[46]  Paul Maruff,et al.  Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. , 2007, Brain : a journal of neurology.

[47]  C. Jack,et al.  Patterns of atrophy differ among specific subtypes of mild cognitive impairment. , 2007, Archives of neurology.

[48]  Charles DeCarli,et al.  Different mechanisms of episodic memory failure in mild cognitive impairment , 2005, Neuropsychologia.

[49]  P. Mecocci,et al.  Vascular Risk Factors in Mild Cognitive Impairment Subtypes , 2007, Dementia and Geriatric Cognitive Disorders.

[50]  C. Jack,et al.  Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI , 2005, Neurology.

[51]  T. Luck,et al.  Mortality in Individuals with Mild Cognitive Impairment , 2007, Neuroepidemiology.

[52]  B L Miller,et al.  Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. , 2001, Archives of neurology.

[53]  B. Horwitz,et al.  Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. , 1992, Journal of computer assisted tomography.

[54]  S. Zeger,et al.  Cognition 6 years after surgical or medical therapy for coronary artery disease , 2008, Annals of neurology.

[55]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.

[56]  Richard Mayeux,et al.  Relation of diabetes to mild cognitive impairment. , 2007, Archives of neurology.

[57]  B. Reisberg,et al.  Mild cognitive impairment in the elderly , 1991, Neurology.

[58]  L. Hansson Antihypertensive treatment and the prevention of dementia: further insights from the Syst-Eur trial. , 1999, Journal of hypertension.

[59]  T. Luck,et al.  Mortality in individuals with mild cognitive impairment. Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). , 2007, Neuroepidemiology.

[60]  C. DeCarli,et al.  Predictors of brain morphology for the men of the NHLBI twin study. , 1999, Stroke.